LLMpediaThe first transparent, open encyclopedia generated by LLMs

AstraZeneca

Generated by Llama 3.3-70B
⚠Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Cheshire Hop 3
Expansion Funnel Raw 72 → Dedup 20 → NER 19 → Enqueued 17
1. Extracted72
2. After dedup20 (None)
3. After NER19 (None)
Rejected: 1 (parse: 1)
4. Enqueued17 (None)
Similarity rejected: 2
AstraZeneca
AstraZeneca
source
NameAstraZeneca
Founded1999
LocationCambridge, United Kingdom

AstraZeneca is a multinational pharmaceutical company that was formed in 1999 through the merger of Astra AB and Zeneca Group. The company has its roots in Sweden and the United Kingdom, with Astra AB being founded in 1913 by Björn Lind and Zeneca Group being demerged from Imperial Chemical Industries in 1993. AstraZeneca is headquartered in Cambridge, United Kingdom and is listed on the London Stock Exchange and the Nasdaq Stockholm. The company is a member of the FTSE 100 Index and the S&P 500.

● History

AstraZeneca's history dates back to the early 20th century, with Astra AB being founded in 1913 in Södertälje, Sweden. The company merged with Zeneca Group in 1999, which was demerged from Imperial Chemical Industries in 1993. The merger was led by Tom McKillop, who became the company's first chief executive officer. In 2000, AstraZeneca acquired Kudos Pharmaceuticals, a biotechnology company based in Cambridge, United Kingdom. The company has since made several acquisitions, including the purchase of MedImmune in 2007, a biotechnology company founded by Wayne Hockmeyer and John D. Baxter. AstraZeneca has also partnered with several companies, including Pfizer, GlaxoSmithKline, and Merck & Co., to develop new treatments for various diseases.

● Products

AstraZeneca has a diverse portfolio of products, including treatments for cancer, cardiovascular disease, respiratory disease, and infectious disease. The company's products include Lynparza, a treatment for ovarian cancer developed in partnership with Merck & Co., and Tagrisso, a treatment for non-small cell lung cancer. AstraZeneca also markets Symbicort, a treatment for asthma and chronic obstructive pulmonary disease, which was developed in partnership with Novartis. The company's products are sold in over 100 countries, including the United States, China, and Japan, and are distributed through a network of pharmacies, hospitals, and healthcare providers.

● Research and Development

AstraZeneca has a strong commitment to research and development, with a focus on developing new treatments for unmet medical needs. The company has research facilities in several locations, including Cambridge, United Kingdom, Gothenburg, Sweden, and Gaithersburg, Maryland. AstraZeneca has partnered with several academic institutions, including University of Cambridge, University of Oxford, and Harvard University, to advance its research and development efforts. The company is also a member of the Innovative Medicines Initiative, a public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations. AstraZeneca has also collaborated with National Institutes of Health, World Health Organization, and Bill and Melinda Gates Foundation to develop new treatments for various diseases.

● Financials

AstraZeneca is a publicly traded company listed on the London Stock Exchange and the Nasdaq Stockholm. The company's revenue has grown steadily over the years, with sales of $24.4 billion in 2020. AstraZeneca's major shareholders include Invesco, Vanguard Group, and BlackRock. The company has a market capitalization of over $100 billion and is a member of the FTSE 100 Index and the S&P 500. AstraZeneca has also been recognized as one of the most innovative companies in the world by Forbes, Bloomberg, and Thomson Reuters.

● Controversies

AstraZeneca has been involved in several controversies over the years, including concerns over the safety and efficacy of its products. The company has faced lawsuits related to its Seroquel product, which has been linked to an increased risk of diabetes and weight gain. AstraZeneca has also faced criticism over its pricing practices, particularly in the United States, where the company has been accused of price gouging. The company has also been involved in a dispute with the European Union over the supply of its COVID-19 vaccine, which was developed in partnership with University of Oxford. AstraZeneca has also faced criticism from World Health Organization, Centers for Disease Control and Prevention, and European Medicines Agency over its handling of the pandemic.

● Corporate Affairs

AstraZeneca is headquartered in Cambridge, United Kingdom and is led by Pascal Soriot, who has been the company's chief executive officer since 2012. The company's board of directors includes Leif Johansson, Graham Chipchase, and Geneviève Berger. AstraZeneca has a strong commitment to corporate social responsibility, with a focus on improving access to healthcare and reducing its environmental impact. The company has partnered with several organizations, including Bill and Melinda Gates Foundation, World Health Organization, and United Nations, to advance its corporate social responsibility efforts. AstraZeneca is also a member of the Pharmaceutical Research and Manufacturers of America and the European Federation of Pharmaceutical Industries and Associations. The company has received several awards, including the Galaxy Award and the Pharmaceutical Executive award, for its commitment to corporate social responsibility and innovation. Category:Pharmaceutical companies

● Some section boundaries were detected using heuristics. Certain LLMs occasionally produce headings without standard wikitext closing markers, which are resolved automatically.